Plunkett Research Online: Arch Biopartners, Inc.

ARCH BIOPARTNERS, INC. (ARCH:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Arch Biopartners Inc is a portfolio based biotechnology company. It focuses on the development of innovative technologies. The company’s portfolio of technology includes AB569 which is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs and urinary tra.....



Arch Biopartners, Inc.
Ticker: ARCH
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 647 428-7031
Fax: 1 647 428-7032
Address: 545 King Street West
Toronto, ON M5V 1M1 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Computer Software (Business and Consumer), Packaged Software and Software as a Service (Saas) Industry
ContactsDescription
Richard MuruveCEO/Director/President/Co-Founder
Andrew BishopCFO/Director
See More
Arch Biopartners Inc is a portfolio based biotechnology company. It focuses on the development of innovative technologies. The company’s portfolio of technology includes AB569 which is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs and urinary tra.....See More See More

Auditor: The Exchange LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: